Eurocell plc Director/PDMR Shareholding (6893G)

TIDMECEL

RNS Number : 6893G

Eurocell plc

27 November 2020

27 November 2020

Eurocell plc

Director/PDMR Shareholding

Eurocell plc (the "Company") announces that, on 25 November 2020:

-- options granted on 4 April 2017 under the Eurocell plc Deferred Share Plan 2015, to acquire ordinary shares in the Company, were exercised by 2 directors; and

-- shares acquired, as a result of the above exercise, were sold by 2 directors to cover the associated tax and national insurance liabilities

The notifications set out below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 
 1.   Details of PDMR / person closely associated with them ("PCA") 
 a)   Name                            A - Mark Kelly 
                                       B - Michael Scott 
     ------------------------------  ------------------------------------------------- 
 2.   Reason for the notification 
     --------------------------------------------------------------------------------- 
 a)   Position / status               A - Chief Executive Officer 
                                       B - Chief Financial Officer 
     ------------------------------  ------------------------------------------------- 
 b)   Initial notification            Initial Notification 
       / amendment 
     ------------------------------  ------------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     --------------------------------------------------------------------------------- 
 a)   Name                            Eurocell plc 
     ------------------------------  ------------------------------------------------- 
 b)   Legal Entity                    213800RH62IQ7S9OFQ55 
       Identifier 
     ------------------------------  ------------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     --------------------------------------------------------------------------------- 
 a)   Description                     Ordinary shares of GBP0.001 each in the Company 
       of the financial                ("Ordinary Shares") 
       instrument                      ISIN Number GB00BVV2KN49 
     ------------------------------  ------------------------------------------------- 
 b)   Nature of the                   Exercise of nil-cost options to acquire ordinary 
       transaction                     shares under the Eurocell plc Deferred Share 
                                       Plan 2015 
     ------------------------------  ------------------------------------------------- 
 c)   Price(s) and                     Price(s)              Volume(s) 
       volume(s)                        A - GBPnil (option    A - 51,049 
                                         price)                B - 14,273 
                                         B - GBPnil (option 
                                         price) 
                                                             ------------ 
     ------------------------------  ------------------------------------------------- 
 d)        Aggregated information 
             *    Aggregated volume 
                                        N/A - single transactions 
 
             *    Aggregated price 
 
 
             *    Aggregated total 
     ------------------------------  ------------------------------------------------- 
 e)   Date of the                     25 November 2020 
       transaction 
     ------------------------------  ------------------------------------------------- 
 f)   Place of the                    Outside a trading venue 
       transaction 
     ------------------------------  ------------------------------------------------- 
 
 
 1.   Details of PDMR / person closely associated with them ("PCA") 
 a)   Name                            A - Mark Kelly 
                                       B - Michael Scott 
     ------------------------------  ------------------------------------------------------- 
 2.   Reason for the notification 
     --------------------------------------------------------------------------------------- 
 a)   Position / status               A - Chief Executive Officer 
                                       B - Chief Financial Officer 
     ------------------------------  ------------------------------------------------------- 
 b)   Initial notification            Initial Notification 
       / amendment 
     ------------------------------  ------------------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     --------------------------------------------------------------------------------------- 
 a)   Name                            Eurocell plc 
     ------------------------------  ------------------------------------------------------- 
 b)   Legal Entity                    213800RH62IQ7S9OFQ55 
       Identifier 
     ------------------------------  ------------------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     --------------------------------------------------------------------------------------- 
 a)   Description                     Ordinary shares of GBP0.001 each in the Company 
       of the financial                ("Ordinary Shares") 
       instrument                      ISIN Number GB00BVV2KN49 
     ------------------------------  ------------------------------------------------------- 
 b)   Nature of the                   Sale of ordinary shares, acquired under the 
       transaction                     Eurocell plc Deferred Share Plan 2015, to cover 
                                       the associated tax and national insurance liabilities 
     ------------------------------  ------------------------------------------------------- 
 c)   Price(s) and                     Price(s)        Volume(s) 
       volume(s)                        A - GBP2.125    A - 24,115 
                                         B - GBP2.125    B - 6,743 
                                                       ----------- 
     ------------------------------  ------------------------------------------------------- 
 d)        Aggregated information 
             *    Aggregated volume 
                                        N/A - single transactions 
 
             *    Aggregated price 
 
 
             *    Aggregated total 
     ------------------------------  ------------------------------------------------------- 
 e)   Date of the                     25 November 2020 
       transaction 
     ------------------------------  ------------------------------------------------------- 
 f)   Place of the                    London Stock Exchange, Main Market (XLON) 
       transaction 
     ------------------------------  ------------------------------------------------------- 
 

For further information:

   Eurocell plc                               01773 842 100 

Paul Walker

Group Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPPGQWGUPUGMQ

(END) Dow Jones Newswires

November 27, 2020 02:00 ET (07:00 GMT)